ESCMID Online Lecture Library. by author
|
|
- Ella Daniels
- 5 years ago
- Views:
Transcription
1 Challenges and Controversies in Vaccination TRAVEL VACCINES Resat Ozaras, MD, Professor, Istanbul University Cerrahpasa Medical School Infectious Dis. Dept.
2
3
4 Risk of exposure The severity of the disease if acquired The risk of the immunization itself
5 Vaccines to Consider for All Destinations Hepatitis A Hepatitis B Tetanus Typhoid Influenza Varicella
6 Mandell s, 7 th Ed.
7 Vaccines for Selected Destinations Mandell s, 7 th Ed.
8 Vaccines for Selected Destinations Yellow fever Meningococcus Rabies Japanese encephalitis (Vero cell) Polio Cholera Tick-borne encephalitis
9 Yellow Fever It falls under the International Health Regulations that may necessitate vaccination purely for regulatory reasons. All healthy adult travelers to areas with a risk of yellow fever transmission should be vaccinated. A country Only a portion of a country. Rare but serious vaccine-associated adverse side effects Persons who are not at any risk of exposure should not be vaccinated. Urban YF in South America: rare Vaccinate persons who will travel anywhere close to regions with risk of transmission.
10 Mandell s, 7 th Ed.
11 A number of African countries (Angola, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Congo, Côte d Ivoire, Democratic Republic of Congo, Gabon, Ghana, Liberia, Mali, Niger, Rwanda, São Tomé, Sierra Leone, Togo) and one in South America (French Guiana) require proof of YF vaccination from all arriving travelers. Other countries, within the risk zone may require an official vaccination certificate for individuals arriving directly from or via (may include a brief transit stop) a country in the YF endemic zone to prevent entry of viremic travelers.
12 Officially valid for 10 years, The true duration of immunity from YF vaccination is probably much longer and may exceed 30 years.
13 Yellow Fever Vaccine Live attenuated virus Single dose Sc Further boster: 10 yr
14 Meningococcus For travelers to Africa s sub- Saharan meningitis belt during the dry season from December through June, especially if prolonged contact with the local population is likely. Out-of-season epidemics have recently occurred in Ethiopia, Somalia, and Tanzania, Possible changes in epidemiologic trends perhaps due to climate changes. Muslims undertaking Hajj and Umrah pilgrimages in Saudi Arabia A higher risk of meningococcal disease, Proof of vaccination with quadrivalent vaccine within the past 3 years is required for visas.
15 Mandell s, 7 th Ed.
16 Meningococcus Vaccine Quadrivalent conjugated polysaccharide (A, C, Y, W135) Single dose IM Further boster: >10 yr
17 Rabies A pre-exposure series for long-stay travel to endemic areas of Latin America, Asia, or Africa, The rabies threat is constant Access to postexposure rabies immune globulin and vaccine is limited. The highest risk Indian subcontinent, Thailand, Vietnam, and most sub- Saharan African countries.
18 Rabies For short-term travel, risk groups: adventure travelers, bikers, hikers, cave explorers, or travelers who travel for short but frequent trips and plan to go running outdoors Regardless of vaccination status, travelers should be instructed to cleanse well with soapy water any bite or animal scratch immediately to seek postexposure treatment for rabies
19 CDC
20 Rabies Inactivated cell culture viral 0, 7, days IM Further boosters: None routinely but two doses after each exposure
21 Japanese Encephalitis Endemic in rural areas of Southeast Asia, Indian subcontinent. Sporadic cases with sequelae continue to occur in travelers. In temperate regions, transmission : April to November. In tropical or subtropical regions of Oceania and Southeast Asia, transmission may occur year round.
22 Japanese Encephalitis Vaccination is recommended for long-stay travel to an endemic rural area; expatriation to anywhere in an endemic country; short-term travel to endemic rural areas with extensive unprotected outdoor exposure, such as with adventure travel; or short-term travel in the face of a current local epidemic. A new, inactivated vero cell JE vaccine with a safety profile replaced the older more toxic mouse brain JE vaccine in 2009
23 Mandell s, 7 th Ed.
24 Japanese encephalitis (Vero cell) Inactivated viral 0, 28 days IM Further boosters:?
25 Polio Because of eradication efforts, poliomyelitis remains in only a few countries, complete control remains elusive Adults traveling to countries that are currently polio endemic and who have previously completed a primary vaccine series Should receive a single dose of inactivated polio vaccine as a booster if the last dose or booster dose was administered >10 years previously.
26 Polio Oral polio is no longer produced in USA Inactivated viral Single dose if adequate childhood series SC, IM Further booster is not needed
27 Mandell s, 7 th Ed.
28 Cholera Cholera vaccination is no longer required by any country, and the risk to typical travelers is insignificant. Medical and aid workers staying for short periods in disaster areas or refugee camps may consider The parenteral inactivated vaccine is no longer available in US and has been officially disowned by WHO A highly effective oral killed whole cell B subunit vaccine is available. This vaccine also has about 50% efficacy against ETEC and a 7-23% efficacy against all traveler s diarrhea (TD)
29 Mandell s, 7 th Ed.
30 Cholera Killed bacteria + recombinant B toxin subunit licensed in some countries for traveler s diarrhea due to ETEC 0, 1 week Oral Further boosters: 2 yr for cholera; 3 mo for ETEC
31 Tick-borne Encephalitis Tick-borne encephalitis (TBE) is an emerging, important, and serious flavivirus central nervous system infection in endemic areas. Distribution is highly focal in a range that extends in a swath from Germany through Scandinavia and the Baltic to Siberia and Vladivostok in the east. Risk to travelers is low BUT extensive outdoor activities in forested regions in endemic areas.
32 Tick-borne Encephalitis Immunization against TBE is recommended for adventure travel, extensive outdoor exposure, or camping in the forests of the endemic countries between April and October. Tick precautions are also recommended. The vaccine is available in most endemic countries and by special release in Canada and UK
33 cdc.gov tbefacts.com
34 Tick-borne Encephalitis Not available in United States Available in endemic areas and in Canada and UK by special release. Inactivated viral 0, 1-3 mo, 9-12 mo IM Further booster: 3 years
35 Notes All currently indicated immunizations can and should be given at the same time and in any combination. If two live viral antigens are not administered on the same day, they must be spaced by a month. Live oral vaccines (typhoid, polio) can be administered at any interval with respect to any live virus vaccine. Minimum intervals between vaccine doses must be respected, although 4 or fewer days before the next interval are acceptable.
36 Interrupted series (except oral typhoid and rabies) need not be restarted but can be resumed beginning with the dose that is overdue. Anaphylactic egg allergy precludes administration of YF, influenza, and MMR vaccines. No current vaccine contains penicillin.
37 Baseline purified protein derivative (PPD) skin tests, often done in the pretravel setting, can be given on the day that live viral vaccines are administered or else must be done more than 4 weeks later. Antibacterial drugs should not be given within 24 hours of a dose of live oral typhoid or oral cholera vaccine. Concomitant mefloquine may interfere with oral typhoid vaccine.
38 Conclusion Apart from routine vaccination, travel to some countries may require others Consider the risk of exposure, the severity of the disease if acquired and the risk of the immunization itself See the references for every destination CDC WHO
39
40
41
Introduction. Infections acquired by travellers
Introduction The number of Australians who travel overseas has increased steadily over recent years and now between 3.5 and 4.5 million exits are made annually. Although many of these trips are to countries
More informationPre- Travel Case Studies (*with Key Pads)
Pre- Travel Case Studies (*with Key Pads) Judi Piasecki, RN, BN Dana Male, RN, BN Pam White RN, BN Certificate in Travel Health A. Which year was the first Manitoba Travel Health Conference? 1. 1999 2.
More informationBelow you will find information about diseases, the risk of contagion, and preventive vaccinations.
Vaccinations Below you will find information about diseases, the risk of contagion, and preventive vaccinations. DTP - Diphtheria Tetanus Polio Yellow fever Hepatitis A Typhoid fever Cerebrospinal meningitis
More informationHIBA ABDALRAHIM Capsca Focal Point Public Health Authority
HIBA ABDALRAHIM Capsca Focal Point Public Health Authority Introduction Definition Symptom Transmission Global situation Local situation Control Content Introduction Yellow fever (YF) is a mosquito-borne
More informationAmerican Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida
Vaccine policy in the US Disease Prevention and Control: Vaccination Recommendations and Travel Medicine Update Lisa A. Klatka, DO, MS Medina County Health Department Medina, OH Manufacturers publish product
More informationThis also applies to all travellers transiting through countries with risk of transmission of yellow fever.
JAMAICA YELLOW FEVER ENTRY REQUIREMENTS 29 MAY 2016 Vaccination against yellow fever is required to prevent the importation of yellow fever virus into Jamaica where the disease does not occur but where
More informationProtecting Yourself Traveler s Health
Protecting Yourself Traveler s Health Diane La May, BSN University of Colorado Hospital International Traveler s Clinic Outline Traveler vaccines Protection from food-borne illness Insect Precautions Safety
More informationFamily and Travel Vaccinations
Family and Travel Vaccinations We offer the full range of baby, child and family vaccinations. We are able to tailor schedules to your child s needs or international schedule. We have a suggested vaccination
More informationCONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN
23 September 2013 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-third session Brazzaville, Republic of Congo, 2 6 September, 2013 Agenda item 14 IMMUNIZATION IN THE AFRICAN REGION: PROGRESS REPORT
More informationTen Travel Medicine Tips
Ten Travel Medicine Tips (New or important things) Joan Ingram ADHB and DML 1. Risks of various health problems during travel Risks vary with destination GeoSentinel Surveillance Network : 30 travel or
More informationYellow fever Vaccine investment strategy
Yellow fever Vaccine investment strategy Background document #5 November 2013 Executive summary Since 2001, GAVI has spent ~$250M on yellow fever control $102M on routine vaccination in 17 countries ~$160M
More informationAnnex 2 A. Regional profile: West Africa
Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationContent. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012
Vol. 2 Issue 3, April 30, 2012 Content Introduction Overview of reported outbreaks in the WHO African Region Cholera Meningitis Ongoing outbreaks Lassa Fever in Nigeria Typhoid in Zimbabwe Meningitis in
More informationSCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE WETENSCHAPPELIJKE STUDIEGROEP REISGENEESKUNDE/GROUPE D'ETUDE SCIENTIFIQUE DE LA MEDECINE DES VOYAGES
SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE WETENSCHAPPELIJKE STUDIEGROEP REISGENEESKUNDE/GROUPE D'ETUDE SCIENTIFIQUE DE LA MEDECINE DES VOYAGES NATIONAL CONSENSUS MEETING Brussels, June 26th, 2015 Presided
More informationAIDS in Africa. An Update. Basil Reekie
AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the
More informationOverview of Travel Medicine
Content Overview of Travel Medicine Concept and Scope of Travel Medicine Pre-travel evaluation & Immunization for traveler Malaria prevention and prophylaxis Case studies returned travelers Watcharapong
More informationTRAVEL VACCINATION. Acknowledgements: Dr Conrad Moreira
TRAVEL VACCINATION Acknowledgements: Dr Conrad Moreira www.who.int www.travelvaccinationcentre.com.a www.traveldoctor.com.au WWW.TRAVELDOCTOR.COM. AU Measles Home grown measles eliminated in Australia
More informationPOLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY
7 July 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-sixth session Addis Ababa, Ethiopia, 28 August 1 September 2006 Provisional agenda item 10.1 POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS
More informationProgress has been made with respect to health conditions.
health Strong performers in reducing child mortality 199-2 Niger Guinea-Bissau Guinea Ethiopia Benin 2 199 Strong performers in reducing maternal mortality 199-2 Djibouti Madagascar Eritrea Comoros Somalia
More informationTHE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026
THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026 Dr Zabulon Yoti WHO AFRO Technical Coordinator for Health Emergencies 1 About 100 acute public health events annually
More informationVaccination-Strategies
Vaccination-Strategies Active immunity produced by vaccine Immunity and immunologic memory similar to natural infection but without risk of disease. General Rule: The more similar a vaccine is to the disease-causing
More informationOh, the Places You ll Go! A Primer on Travel Health and Immunizations August 2016 Tanya Chadwell FNP-BC
Oh, the Places You ll Go! A Primer on Travel Health and Immunizations August 2016 Tanya Chadwell FNP-BC Main Goals of Travel Medicine Mitigate risk of illness and disease by Education on Preventive Measures
More informationEconomics of Vaccine Development A Vaccine Manufacturer s Perspective
Economics of Vaccine Development A Vaccine Manufacturer s Perspective Gerald Voss The Value of Vaccines 2 29 diseases are currently preventable by vaccination Global public health Cervical cancer 1 Diphtheria
More informationAdvisory on Plague WHAT IS PLAGUE? 19 October 2017
19 October 2017 Advisory on Plague WHAT IS PLAGUE? Plague is an infectious disease caused by the zoonotic bacteria, Yersinia pestis. This bacteria often infects small rodents (like rats, mice, and squirrels)
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More information1.0 ROUTINE SCHEDULES...
August 2012 TABLE OF CONTENTS 1.0 ROUTINE SCHEDULES... 1 1.1 SCHEDULE A: BASIC IMMUNIZATION WHEN STARTING WITH INFANRIX HEXA VACCINE... 1 1.1.1 SCHEDULE A: BASIC IMMUNIZATION WHEN STARTING WITH PEDIACEL
More information9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in
More informationPOLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12
5 August 9 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, August 4 September 9 POLIOMYELITIS ERADICATION: PROGRESS REPORT Information Document CONTENTS
More informationBethel s Global Reach GOING DOING. Kenya, Africa Missions Trip June 1-11, 2019
Bethel s Global Reach GOING DOING www.bethelsglobalreach.org Kenya, Africa Missions Trip June 1-11, 2019 Marcus D. Holman mholman@bethelsglobalreach.org Katherine Carey kcarey@bethelsglobalreach.org Darrellon
More informationMain global and regional trends
I N T R O D U C T I O N Main global and regional trends Promising developments have been seen in recent years in global efforts to address the AS epidemic, including increased access to effective treatment
More informationTRAVEL IMMUNISATION UPDATE 2017 V 2.0. Dr Nick Kimpton MBBS FRACGP CTH MPHTM Ballarat Medical Centre 10 Drummond St South Ballarat 3350 Ph
TRAVEL IMMUNISATION UPDATE 2017 V 2.0 Dr Nick Kimpton MBBS FRACGP CTH MPHTM Ballarat Medical Centre 10 Drummond St South Ballarat 3350 Ph 53331253 ROUTINE VACCINATIONS [NOT SPECIFIC TO TRAVEL] DTP
More informationTravel. Program Management. Schedule
Program Management 69_4 YF (yellow fever) vaccine should be offered to all travellers to and from at-risk areas, unless they belong to the group of individuals for whom YF vaccination is contraindicated.
More informationSpecific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner
Specific issues related to FMD surveillance in the eastern Africa sub-region Gideon Brückner 1 Why do we do surveillance for FMD? Demonstrating freedom from FMD, FMDV infection and/or FMDV transmission
More informationPrioritizing Emergency Polio Eradication Activities
Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b
More information2018 AOCOPM Midyear Educational Conference San Antonio
FAQs $100 $200 $300 $400 $500 Current Concepts in Vaccination Vaccinepreventable diseases Special populations I m Leavin on a jet plane What s new? $100 $100 $100 $100 $200 $200 $200 $200 $300 $300 $300
More informationGlobal Burden of Meningococcal Disease. Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London.
Global Burden of Meningococcal Disease Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London. Neisseria meningitidis Gram negative diplococci. Ten
More information2/20/2019. The need for adult vaccinations. Update on Adult Immunizations. The Need for Adult Vaccinations. Objectives:
The need for adult vaccinations Update on Adult Immunizations Objectives: Recall the latest recommendations on adult vaccinations Detail the importance of adult vaccinations I m not a kid.. Why are you
More informationTravel Medicine 101: Pre-Travel Consultation. Keyur S. Vyas, MD UAMS Division of Infectious Diseases September 7 th, 2018
Travel Medicine 101: Pre-Travel Consultation Keyur S. Vyas, MD UAMS Division of Infectious Diseases September 7 th, 2018 Travel Medicine Aim of pre-travel consultation is to prevent disease and injury
More informationMalaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA
Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?
More informationANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA
4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION
More informationTwinrix Combined Hep A and B
Twinrix Combined Hep A and B Cost $70.00 per injection. 3 required Standard course: 0, 1, 6 months Blood test recommended after course complete site of injection Vaqta Hepatitis A Vaccine Adults: cost
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationUpdate on Meningococcal A Vaccine Development and Introduction
Update on Meningococcal A Vaccine Development and Introduction WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC) @ Geneva, 7-9 September 2015 Dr Marie-Pierre Preziosi, WHO Initiative
More informationOur Mission. To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers
Our Mission To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers The Travel Clinic utilizes national and international travel
More informationFRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat
13 June 2017 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-seventh session Victoria Falls, Republic of Zimbabwe, 28 August 1 September 20177 Provisional agenda item 11 FRAMEWORK FOR IMPLEMENTING
More informationWhat is this document and who is it for?
Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination
More information( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI
( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI Long partnership between; IRRI & PhilRice IRRI & JICA PhilRice & JICA The Season Long
More informationPublic Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
More informationContent. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 4, 26 May 2012
Vol. 2 Issue 4, 26 May 2012 Content Introduction Overview of reported outbreaks in the WHO African Region Cholera Meningitis Ongoing outbreaks Cholera in Ghana Cholera in Mozambique Cholera in Uganda Cholera
More informationInfectious Diseases Consultants of Oklahoma City
Infectious Diseases Consultants of Oklahoma City Travel Clinic Questionnaire Patient Name:. DOB: / /. q first visit q return visit Adress: Phone: Primary Purpose of travel: q Business q Personal q Mission
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More informationHepatitis B and C Basics
Hepatitis B and C Basics What is the liver? The liver is the largest internal organ that performs many important functions. Stores nutrients and vitamins Fights infection Stores energy Removes harmful
More informationFighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010
Fighting Harder and Smarter Against Malaria Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010 Outline Burden of malaria Global support for rolling back malaria
More informationUpdate from GAVI Aurelia Nguyen
Update from GAVI Aurelia Nguyen (Copenhagen, Denmark, 27 June 2012) GAVI vaccine support Currently supported vaccines: pentavalent, pneumococcal, rotavirus, meningitis A, human papillomavirus (HPV), rubella,
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationImmunization in Cancer Patients:
Immunization in Cancer Patients: An Often Forgotten or Ignored Responsibility E.J. Bow MD, MSc., D. Bacteriol., FRCPC Infectious Diseases, Haematology/Oncology, Blood and Marrow Transplant Director, Infection
More informationSeries of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)
UTAH PREVENTIVE CARE RECOMMENDATIONS Adult - Ages 19 and Above IMMUNIZATIONS CONTENTS: General Instructions Hepatitis A Hepatitis B Human Papilloma Virus Influenza Meningococcal A, C, Y, W (MCV4) Meningococcal
More informationComparative Analyses of Adolescent Nutrition Indicators
Comparative Analyses of Adolescent Nutrition Indicators Rukundo K. Benedict, PhD The DHS Program Stakeholders Consultation on Adolescent Girls Nutrition: Evidence, Guidance, and Gaps October 30 31, 2017
More informationStainless-steel vs Single-use: The Vaccines Perspective
Stainless-steel vs Single-use: The Vaccines Perspective CMO-Biomanufacturer Panel Tue 21 April, Noon-1:30pm, Exhibit Hall Daniel C.Vellom, PhD Sr. Director Global Technology Innovation 2015 INTERPHEX 1
More informationChildren in Africa. Key statistics on child survival, protection and development
Children in Key statistics on child survival, protection and development Key Statistics In, mortality rates among children under five decreased by 48 per cent between 199 and 13, but still half of the
More informationGlobal summary of the AIDS epidemic, December 2007
Global summary of the AIDS epidemic, December 27 Number of people living with HIV in 27 Total Adults Women Children under 15 years 33.2 million [3.6 36.1 million] 3.8 million [28.2 33.6 million] 15.4 million
More informationP L E A S E N O T E - There will be a charge for each person, even if your travel has been discussed previously with your own GP.
I M P O R T A N T - It is preferable that your Travel Consultation appointment is made one month prior to your departure. Please return this record this form promptly. You will be advised of an appointment
More informationBELGIAN CONSENSUS MEETING ON TRAVEL MEDICINE
BELGIAN CONSENSUS MEETING ON TRAVEL MEDICINE 25-05-2012 The consensus meeting was chaired by A. Van Gompel. Secretary of the meeting was W. Peetermans. A PowerPoint presentation was prepared by A. Van
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationInfluenza Surveillance In the WHO African Region
Vol. 2 N 52, Updated on 2 January 207 Contents Highlights ackground Methodology Review of 206 influenza virus circulation Seasonal patterns of influenza transmission Way forward Conclusion Editor Dr Ibramima
More informationPROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS
29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A
More informationImmunisations and Health Information for Travel See the Bibliography for further information
Chapter 5 for Travel 05 Health Information for Travel See the Bibliography for further information In some circumstances, advice in these guidelines may differ from that in the Summary of Product Characteristics
More informationVaccine. Specific defenses Immunity. natural. acquired. Live vaccines. Killed Inactivated vaccines. Cellular fraction vaccines
Introduction Vaccine has been a importance medical breakthrough in preventing morbidity and mortality from infectious diseases worldwide. Vaccination has managed to eradicate the deadly and mutilating
More informationExperiences on Workforce Development in Other Regions
Experiences on Workforce Development in Other Regions The USA Experience John MacArthur, MD, MPH (EIS 98) Director Thailand MOPH US CDC Collaboration CDC/Southeast Asia Regional Office Epidemic Intelligence
More informationCDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN
CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN 2010-2012 14 Sept-10 2010 First and Second Quarters (January June) Geographic distribution of wild poliovirus (WPV)
More informationThis is risky. Rabies. Are you at risk?
This is risky. Rabies Are you at risk? Are you at risk of rabies? You are at risk if you are in contact with potentially rabid animals: t Laboratory workers, veterinarians t Animal control workers, animal
More informationPRE- TRAVEL QUESTIONNAIRE
Ph: 03 313 7877 Fax: 03 313 7861 Email: admin@medicalcorner.co.nz 237 High Street, Rangiora 7400 PRE- TRAVEL QUESTIONNAIRE Please add as much detail to this form as possible as this will ensure that the
More informationPROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA
5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR
More informationBiosecurity, biobanking and data management during public health crises in Africa. A peer into the future.
Biosecurity, biobanking and data management during public health crises in Africa. A peer into the future. Akin Abayomi, EU BBMRI ERIC meeting, Brusells, April 2017 Public Health Crises and the era of
More informationTel:
A/Prof Joe Torresi Department of Infectious Diseases Austin Hospital Austin Centre for Infection Research Department of Medicine (Austin Health) The University of Melbourne Tel: 61 3 9496 6676 josepht@unimelb.edu.au
More informationImmunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
More informationAnnex 1. WHO Recommendations, Guidelines and other documents related to the manufacture and quality control of biological substances used in medicine
WHO related to the manufacture and quality control of biological substances used in medicine WHO are intended to provide guidance to those responsible for the production of biological substances as well
More informationInterrupted primary series***
(Updated March 2017) Table 3: Recommendations* for Interrupted or Delayed Routine Immunization - Summary of WHO Position Papers Antigen Age of 1st Dose Doses in Primary Series (min interval between s)**
More informationInterrupted primary series***
(Updated April 2018) Table 3: Recommendations* for Interrupted or Delayed Routine Immunization - Summary of WHO Position Papers Antigen Age of 1st Dose Doses in Primary Series (min interval between s)**
More informationYellow Fever = Bad Disease
Yellow Fever = Bad Disease Dr. David O Freedman Unvaccinated engineer after Amazon trip. Hepatic encephalopathy, ARDS, coma, DIC with spontaneous bleeding. Gross hematuria, 3+ proteinuria, BUN 81, Creatinine
More informationScaling Up Nutrition Action for Africa
Scaling Up Nutrition Action for Africa Where are we and what challenges are need to be addressed to accelerate malnutrition? Lawrence Haddad Global Alliance for Improved Nutrition Why should African political
More informationUNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: Fax: N Medical Dr. Salt Lake City, UT 84132
Welcome to UNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: 801-801-581-2898 Fax: 801-585-7315 50 N Medical Dr. Salt Lake City, UT 84132 Our goal is to help you have a safe and enjoyable experience
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationBODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES
BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES Topic 3 This topic links in with MICROBES (from unit 1) 1. What are the 3 types of microbes? 2. Which microbe do antibiotics destroy? 3. What microbe
More informationHistory and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
More informationRotavirus vaccines: Issues not fully addressed in efficacy trials
Rotavirus vaccines: Issues not fully addressed in efficacy trials TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines Licensed in 2006
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
More informationGeneral information. Sri Lanka. Provided by NaTHNaC https://travelhealthpro.org.uk 10 Apr 2018
Sri Lanka Capital City : "Colombo (executive and judicial) and Sri Jayewardenepura Kotte (Colombo suburb; legislative)" Official Language: "Sinhala, Tamil" Monetary Unit: "Sri Lankan rupee (LKR)" General
More informationCDER EDITORIAL Through this issue of the
REGIONAL OFFICE FORAfrica DATA VALID EFFECTIVE 17 FEBRUARY 2010 In this issue CDER Editorial 65 Breaking news: cerebrospinal meningitis epidemics 65 Summary findings from IDSR weekly surveillance of diseases
More informationIMMUNIZATION & VACCINE PREVENTABLE DISEASES
IMMUNIZATION & VACCINE PREVENTABLE DISEASES MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2015 (Vol 3, issue N 6 ) Special issue on WHO/UNICEF Estimates of National Immunization Coverage
More informationabout VFR Parents and Children
Pre-CISTM Course, 24 May 2015 : Pediatric Travel Medicine: what we know, what we think we know and what we actually end up doing! about VFR Parents and Children Stefan Hagmann, MD MSc Associate Professor
More informationWashtenaw County Community Mental Health HEALTH CARE PERSONNEL (HCP) VACCINES (RECOMMENDED EMPLOYEE IMMUNIZATIONS)
Washtenaw County Community Mental Health HEALTH CARE PERSONNEL (HCP) VACCINES (RECOMMENDED EMPLOYEE IMMUNIZATIONS) PURPOSE To reduce the risk of exposure of Washtenaw County Community Mental Health (CMH)
More information*Indian currency is also accepted legal tender; the ngultrum is at par with the Indian rupee
Bhutan *Indian currency is also accepted legal tender; the ngultrum is at par with the Indian rupee Capital City : "Thimphu" Official Language: "Dzongkha (a Tibetan dialect)" Monetary Unit: "ngultrum (Nu)*"
More informationDeaths/yr Efficacy Use Prev Deaths/yr. Influenza 36,000 70% 60% 18,000. Pneumonia 40,000 60% 40% 20,000 HBV 6,000 90% 30% 4,000
Tetanus, Diptheria, Pertussis,! Measles, Mumps, Rubella, Varicella, HPV, Polio Meningococcus, Pneumococcus,! Influenza, Hepatitis B, Hepatitis A,! H influenza, Rabies, Typhoid,! Yellow Fever, Japanese
More informationPlease read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture. Chapters 9, 17 and 8 for next Friday s lectures
Valerie Daggett Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture Chapters 9, 17 and 8 for next Friday s lectures ppt files for first 2 lectures Past exams Principles of
More informationAfrica s slow fertility transition
Africa s slow fertility transition John Bongaarts Population Council, New York Süssmilch Lecture Max Planck Institute, Rostock 3 Sep 215 Billions 4 3 Population projections for sub-saharan Africa 215 projection
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2016 (Vol 4, issue N 5) Special issue on 2015 WHO/UNICEF Estimates of National Immunization Coverage (WUENIC)
More information